Investing Profile

Jay Lichter

VCInvestor
Managing Director at Avalon Ventures
Photo of Jay Lichter, Avalon Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$1M - $10.0M
$5.0M
19
$116M
CompanyStageDateRound SizeTotal Raised
AeroRx Therapeutics
Series AOct 2025$21M
$21M
Enlaza Therapeutics
Series AApr 2024$100M
SeedOct 2022$61M
$160M
Co-investors: Stephen Squinto (OrbiMed), James N. Topper (Frazier Healthcare Partners), Marcos Milla (Samsara BioCapital)
Arialys Therapeutics
SeedSep 2023$58M
$58M
Janux Therapeutics
Series BApr 2021$130M
Series AMar 2021$56M
$180M
Co-investors: Peter Thompson (OrbiMed), Jake Simson (RA Capital)
AristaMD
Series BMar 2020$18M
Series AJul 2016$11M
$35M
Co-investors: Payal Agrawal Divakaran (.406 Ventures), John Kuelper (Ascension Ventures)
Avelas Biosciences
Series CAug 2016$20M
Series BSep 2014$7M
Series BJan 2014$7M
Series ADec 2012$8M
$42M
Co-investors: Kevin Kinsella (Avalon Ventures)
Thyritope Biosciences
Series ASep 2014$10M
$10M
Silarus Therapeutics
Series ASep 2014$10M
$10M